LIPAC Oncology is a clinical stage pharmaceutical company employing LiPax,™ its proprietary proliposomal intracavitary paclitaxel drug delivery platform, to enhance and reformulate proven cancer drugs into more effective treatments. LiPax, a locally delivered formulation of paclitaxel, is being developed for the intravesical treatment of non-muscle invasive bladder cancer (NMIBC) and other intracavitary cancer indications. ...
LIPAC Oncology is a clinical stage pharmaceutical company employing LiPax,™ its proprietary proliposomal intracavitary paclitaxel drug delivery platform, to enhance and reformulate proven cancer drugs into more effective treatments. LiPax, a locally delivered formulation of paclitaxel, is being developed for the intravesical treatment of non-muscle invasive bladder cancer (NMIBC) and other intracavitary cancer indications.
LiPax is a next generation localized proliposomal formulation of paclitaxel that targets numerous solid tumor carcinomas that are difficult to treat.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.